Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Zhang, Weiguo ^a   Shi, Heidi Y ^a   Zhang, Ming ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8 INHIBITOR; CASPASE INHIBITOR; CYTOCHROME C; MASPIN; PROTEIN BAX; PROTEIN BCL 2; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; CASP8 PROTEIN, HUMAN; CASP8 PROTEIN, MOUSE; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; ENZYME INHIBITOR; RIBONUCLEASE; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN FAMILY; PROTEIN STABILITY; REGULATORY MECHANISM; STRESS; TUMOR CELL; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL LINE; CULTURE MEDIUM; CYTOSOL; DISEASE COURSE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; STATISTICAL MODEL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 8; CASPASE 9; CASPASE INHIBITORS; CELL LINE; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; CYTOCHROMES C; CYTOSOL; DISEASE PROGRESSION; DNA, COMPLEMENTARY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; MICE; MICROSCOPY, FLUORESCENCE; MODELS, STATISTICAL; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBONUCLEASES; SERPINS; STAUROSPORINE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26844495642     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-50     Document Type: Article

References (38)

1. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells [see comments]. Science 1994, 263:526-529.
2. Sager R, Sheng S, Pemberton P, Hendrix MJ: Maspin: a tumor suppressing serpin. Curr Top Microbiol Immunol 1996, 213:51-64.
3. Zhang M, Maass N, Magit D, Sager R: Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 1997, 8:179-186.
4. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000, 275:6051-6054.
5. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE: Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 2002, 31:175-179.
6. Sheng S, Pemberton PA, Sager R: Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 1994, 269:30988-30993.
7. Zhang M, Volpert O, Shi YH, Bouck N: Maspin is an angiogenesis inhibitor. Nat Med 2000, 6:196-199.
8. Zhang M, Shi Y, Magit D, Furth PA, Sager R: Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene 2000, 19:6053-6058.
9. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH: The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 1997, 3:1949-1958.
10. Zhang M, Magit D, Botteri F, Shi Y, He K, Li M, Furth P, Sager R: Maspin plays an important role in mammary gland development. Developmental Biology 1999, 215:278-287.
11. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S: Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002, 21:4089-4098.
12. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D, Zhang M: Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 2001, 61:6945-6951.
13. Latha K, Zhang W, Cella N, Shi HY, Zhang M: Maspin Mediates Increased Tumor Cell Apoptosis upon Induction of the Mitochondrial Permeability Transition. Mol Cell Biol 2005, 25:1737-1748.
14. Kulik G, Carson JP, Vomastek T, Overman K, Gooch BD, Srinivasula S, Alnemri E, Nunez G, Weber MJ: Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells. Cancer Res 2001, 61:2713-2719.
15. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
16. Takahashi A, Hirata H, Yonehara S, Imai Y, Lee KK, Moyer RW, Turner PC, Mesner PW, Okazaki T, Sawai H, Kishi S, Yamamoto K, Okuma M, Sasada M: Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene 1997, 14:2741-2752.
17. Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999, 11:255-260.
18. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995, 270:3255-3260.
19. Bird CH, Sutton VR, Sun J, Hirst CE, Novak A, Kumar S, Trapani JA, Bird PI: Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 1998, 18:6387-6398.
20. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A 1996, 93:11669-11674.
21. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
22. Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M: Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 2001, 61:1699-1706.
23. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
24. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM: Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 1999, 189:1815-1822.
25. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
26. Reed JC: Cytochrome c: can't live with it--can't live without it. Cell 1997, 91:559-562.
27. Maki CG, Huibregtse JM, Howley PM: In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 1996, 56:2649-2654.
28. Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM: Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell 2000, 11:1555-1569.
29. Yethon JA, Epand RF, Leber B, Epand RM, Andrews DW: Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem 2003, 278:48935-48941.
30. Malina HZ, Hess OM: Xanthurenic acid translocates proapoptotic Bcl-2 family proteins into mitochondria and impairs mitochondrial function. BMC Cell Biol 2004, 5:14.
31. Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K: Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 2004, 200:223-234.
32. Lajmanovich A, Irisarri M, Molens JP, Pasquier MA, Sotto JJ, Bensa JC, Leroux D, Plumas J: Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells. Br J Haematol 2004, 124:746-753.
33. Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW, Oh YJ: Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8-and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 2004, 279:20451-20460.
34. Gilot D, Loyer P, Corlu A, Glaise D, Lagadic-Gossmann D, Atfi A, Morel F, Ichijo H, Guguen-Guillouzo C: Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione Stransferase regulation. J Biol Chem 2002, 277:49220-49229.
35. LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS: 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003, 63:468-475.
36. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
37. Deng Y, Lin Y, Wu X: TRAIL-induced apoptosis requires Baxdependent mitochondrial release of Smac/DIABLO. Genes Dev 2002, 16:33-45.
38. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348.